Press Announcements > FDA approves pill with sensor that digitally tracks if patients have ingested their medication

Press Announcements > FDA approves pill with sensor that digitally tracks if patients have ingested their medication

FDA approves pill with sensor that digitally tracks if patients have ingested their medication
New tool for patients taking Abilify

The U.S. Food and Drug Administration today approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole tablets with sensor) has an ingestible sensor embedded in the pill that records that the medication was taken. The product is approved for the treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder and for use as an add-on treatment for depression in adults. Continue reading.